Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
AOD-9604 is generally well-tolerated with a favorable safety profile based on clinical research involving approximately 900 participants across six studies
The peptide BPC-157 has not been evaluated for safety as part of the drug review process of the United States Food and Drug Administration (FDA), nor has it been formally evaluated for safety by any international regulatory counterpart of the FDA
Reference: Malinda KM et al
requires FAD as a cofactor FMO3 breaks down trimethylamine and other compounds
Prvention ou traitement du stress (caus par la vaccination, les maladies, le transport, une humidit leve, des tempratures leves ou des variations extrmes de temprature)
The promoting effect of pentadecapeptide BPC 157 on tendon healing. J Appl Physiol 2011
